Equifax CTO Jamil Farshchi reports stock sales, option exercise

Equifax Inc. executive Jamil Farshchi, EVP and Chief Technology Officer, reported multiple stock transactions.

Rhea-AI Filing Summary

Equifax Inc. executive Jamil Farshchi, EVP and Chief Technology Officer, reported multiple stock transactions. On 02/10/2026 he exercised a stock option for 6,213 shares of common stock at $191.44 per share and received an additional 4,667 common shares as a grant at $0.0000 per share. To cover obligations, 3,042 shares were withheld at $202.71 per share. On 02/10/2026 he sold 6,213 common shares at $195.81 per share, and on 02/11/2026 he sold 1,167 common shares at $199.87 per share. The sales were made under a Rule 10b5-1 trading plan adopted on 4/25/2025, and he held 39,869 common shares directly after the reported transactions.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Farshchi Jamil

Role EVP, Chief Technology Officer

Sold 7,380 shs ($1.45M)

Approx. gross sale proceeds $1.45M

Approx. exercise cost $1.19M

Type	Security	Shares	Price	Value
Sale	Common Stock	1,167	$199.87	$233K
Exercise	Stock Option/Right to Buy	6,213	$0.00	$0.00
Exercise	Common Stock	6,213	$191.44	$1.19M
Grant/Award	Common Stock	4,667	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,042	$202.71	$617K
Sale	Common Stock	6,213	$195.81	$1.22M

Holdings After Transaction: Stock Option/Right to Buy — 0 contracts (Direct); Common Stock — 39,869 shares (Direct)

Footnotes (3)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.
2. F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
3. F3. The option vested in three equal annual increments beginning 2/21/2021.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Equifax (EFX) executive Jamil Farshchi report?

Jamil Farshchi reported exercising 6,213 stock options, receiving 4,667 granted shares, and selling 7,380 Equifax common shares at prices between $195.81 and $199.87. He also had 3,042 shares withheld at $202.71 to cover obligations, and held 39,869 shares afterward.

Were Jamil Farshchi’s Equifax (EFX) stock sales under a 10b5-1 plan?

Yes. The filing states the reported sales were effected under a Rule 10b5-1 trading plan adopted by Jamil Farshchi on April 25, 2025. Such pre-arranged trading plans allow scheduled transactions, helping separate personal trading decisions from day-to-day corporate information.

How many Equifax (EFX) shares did Jamil Farshchi sell in this Form 4?

He sold 6,213 Equifax common shares at $195.81 on February 10, 2026 and 1,167 shares at $199.87 on February 11, 2026. These open-market sales were reported as direct transactions and executed under his Rule 10b5-1 trading plan.

What Equifax (EFX) stock awards or acquisitions did Jamil Farshchi report?

He reported acquiring 6,213 Equifax common shares by exercising a stock option at $191.44 per share and receiving 4,667 common shares at $0.0000 per share as a grant or award. These transactions increased his direct holdings before subsequent tax withholding and sales.

How many Equifax (EFX) shares does Jamil Farshchi own after these transactions?

After the reported transactions, Jamil Farshchi directly owned 39,869 Equifax common shares. This figure reflects option exercises, share grants, tax-withholding disposals, and open-market sales reported for February 10 and February 11, 2026 in the Form 4 filing.

What is the nature of the Equifax (EFX) option exercised by Jamil Farshchi?

He exercised a stock option covering 6,213 Equifax common shares with an exercise price of $191.44 per share. The option vested in three equal annual increments beginning February 21, 2021, and was reported as a direct derivative conversion on February 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farshchi Jamil

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		M(1)		6,213	A	$191.44	45,624(2)	D
Common Stock	02/10/2026		A		4,667	A	$0.0000	50,291(2)	D
Common Stock	02/10/2026		F		3,042	D	$202.71	47,249(2)	D
Common Stock	02/10/2026		S(1)		6,213	D	$195.81	41,036(2)	D
Common Stock	02/11/2026		S(1)		1,167	D	$199.87	39,869(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option/Right to Buy	$191.44	02/10/2026		M			6,213	(3)	02/21/2026	Common Stock	6,213	$0.0000	0.0000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.

2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

3. The option vested in three equal annual increments beginning 2/21/2021.

	/s/Lisa Stockard as Attorney-in-Fact	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.